Arsenal Biosciences
Focus: Arsenal Biosciences is a public oncology-focused biotech company headquartered in South San Francisco, developing novel cancer immunotherapies and supportive care treatments.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
Recent layoff filing — 100 affected
- 9/16/2025 — 329 Oyster Point Blvd. South San Francisco CA 94080, CA · 100 affected · Layoff
Source: state DOL filings via Big Local News
About Arsenal Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Arsenal Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NeoCast Embolic System
Subdural HematomaClinical Trials (1)
NCT07541404MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma
N/AHelp build intelligence for Arsenal Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.